KIF5B-MET fusion variant in non-small cell lung cancer
Open Access
- 30 July 2022
- journal article
- letter
- Published by Taylor & Francis in Pulmonology
- Vol. 28 (4) , 315-316
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- MET-dependent solid tumours — molecular diagnosis and targeted therapyNature Reviews Clinical Oncology, 2020
- Detection of Novel NRG1, EGFR, and MET Fusions in Lung Adenocarcinomas in the Chinese PopulationJournal of Thoracic Oncology, 2019
- Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung CancerNeoplasia, 2018
- Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma PatientsClinical Cancer Research, 2018
- KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung AdenocarcinomaJournal of Thoracic Oncology, 2018
- Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine KinasesCancer Research, 2016
- The landscape of kinase fusions in cancerNature Communications, 2014
- Crizotinib Can Overcome Acquired Resistance to CH5424802: Is Amplification of the MET Gene a Key Factor?Journal of Thoracic Oncology, 2014